The immunomodulatory enzyme IDO2 is an essential mediator of autoantibody production and joint inflammation in preclinical models of autoimmune arthritis. Although originally identified as a tryptophan-catabolizing enzyme, we recently discovered a previously unknown nonenzymatic pathway is essential for the proarthritic function of IDO2. We subsequently identified Runx1 (Runt-related transcription factor 1) as a potential component of the nonenzymatic pathway IDO2 uses to drive arthritis.
View Article and Find Full Text PDFIDO2 is one of two closely related tryptophan catabolizing enzymes induced under inflammatory conditions. In contrast to the immunoregulatory role defined for IDO1 in cancer models, IDO2 has a proinflammatory function in models of autoimmunity and contact hypersensitivity. In humans, two common single-nucleotide polymorphisms have been identified that severely impair IDO2 enzymatic function, such that <25% of individuals express IDO2 with full catalytic potential.
View Article and Find Full Text PDFIndoleamine-2,3-dioxygenase (IDO)1 and IDO2 are two closely related tryptophan catabolizing enzymes encoded by linked genes. The IDO pathway is also immunomodulatory, with IDO1 well-characterized as a mediator of tumor immune evasion. Due to its homology with IDO1, IDO2 has been proposed to have a similar immunoregulatory function.
View Article and Find Full Text PDFBuilding on Preston and Campbell's two-sex model of intergenerational transmission, this article provides a theoretical analysis of the dynamics of the racial distribution in black-white-mulatto systems. The author shows that "bounded" patterns of racial classification and switching imply long-run racial homogeneity in the absence of differential reproduction. Beyond the theoretical analysis, the author attempts to account for the dramatic growth of the white population share in Puerto Rico in the early 20th century.
View Article and Find Full Text PDF